Trade Mark Journal No.2026/021 22 May 2026
UK00004383524 6 May 2026 (40)

- Class 40
- Custom manufacture of pharmaceuticals; custom manufacture of medicines for the treatment of neuroscience, immunology, cell biology and oncology related therapy by pharmaceutical compounders.
GI Accelerate Parent LP
Representative: Barker Brettell LLP